when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

calendar

1 catalysts · 1 phase 0 trial completion

★ save view ↓export CSV

next 91 dayslessmore

MonWedFri

view

sort

soonest latest type sponsor alpha

TA: ophthalmology×from 2026-04-25×to 2026-04-25×clear all

search

type

phase 0 trial completion1

therapy area

Oncology12
Immunology4
Infectious Disease3
Pain1

Pulmonology

1

Women's Health1

Week of Apr 20, 2026

1

›Apr 25, 2026phase 0 trial completion108d agoExegenesis Bio Inc — EXG-202 (Phase 0 Trial Completion)EXG-202

Therapy area: Ophthalmology. Indication: Age Related Macular Degeneration, Macular Degeneration, Wet (Neovascular / Exudative) Macular Degeneration

full page →EXG-202 →source: globaldata